Page last updated: 2024-09-04
docetaxel anhydrous and fr 190997
docetaxel anhydrous has been researched along with fr 190997 in 1 studies
Compound Research Comparison
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (fr 190997) | Trials (fr 190997) | Recent Studies (post-2010) (fr 190997) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 25 | 0 | 6 |
Protein Interaction Comparison
Protein | Taxonomy | docetaxel anhydrous (IC50) | fr 190997 (IC50) |
---|---|---|---|
B2 bradykinin receptor | Cavia porcellus (domestic guinea pig) | 0.0023 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0004 | |
B2 bradykinin receptor | Homo sapiens (human) | 0.0004 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Afratis, K; Gavras, H; Karamanos, NK; Koutsakis, C; Leonardi, S; Papaioannou, D; Piperigkou, Z; Rassias, G; Rigopoulou, D; Vachlioti, E | 1 |
Other Studies
1 other study(ies) available for docetaxel anhydrous and fr 190997
Article | Year |
---|---|
Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?
Topics: Anti-Bacterial Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 Cells; Quinolines; Receptor, Bradykinin B2 | 2021 |